Literature DB >> 437044

Transdermal uptake of a peptide hormone: inhibition by calcitonin eardrops of induced osteolysis in guinea-pig ossicles.

C G Rudman, J A Parsons.   

Abstract

In view of a recent proposal that calcitonin injections may arrest the bony pathology of otosclerosis, we have tested the possibility of obtaining locally effective concentrations by giving salmon calcitonin in eardrops. Osteolysis of guinea-pig ossicles induced by injecting parathyroid hormone shortly before explantation was markedly inhibited by 3 days prior instillation of the calcitonin in an aqueous vehicle or in dimethyl sulphoxide, but not by a solution in propylene carbonate.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 437044     DOI: 10.1007/bf01922745

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  7 in total

1.  Effect of calcitonin treatment on deafness due to Paget's disease of bone.

Authors:  L R Solomon; J M Evanson; D P Canty; N W Gill
Journal:  Br Med J       Date:  1977-08-20

Review 2.  Physiologic and pharmacologic regulation of bone resorption.

Authors:  L G Raisz
Journal:  N Engl J Med       Date:  1970-04-16       Impact factor: 91.245

3.  Effects of calcitonin therapy in deafness associated with Paget's disease of bone.

Authors:  W H Moffatt; J D Morrow; N Simpson
Journal:  Br Med J       Date:  1974-10-26

4.  Treatment with calcitonin.

Authors:  P B O'Neill
Journal:  Br Med J       Date:  1973-03-24

5.  A study of the stability of calcitonin biological activity.

Authors:  F E Newsome; R K O'Dor; C O Parkes; D H Copp
Journal:  Endocrinology       Date:  1973-04       Impact factor: 4.736

Review 6.  The chemistry of parathyroid hormone and the calcitonins.

Authors:  J T Potts; H T Keutmann; H D Niall; G W Tregear
Journal:  Vitam Horm       Date:  1971       Impact factor: 3.421

7.  The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.

Authors:  F Shai; R K Baker; S Wallach
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.